Nearly 80% of Execs See ROI from Clinical Surveillance Tools
- Healthcare executives are generally seeing a return on investment (ROI) from their clinical surveillance tools, revealed a survey conducted by Sage Growth Partners (SGP) and commissioned by VigiLanz. However, some believe that solutions built into their electronic health records (EHRs) aren’t satisfying all their data analytics needs. Ninety-six percent of executives said they...